biblio

Export 14 results:
Filters: Author is Sarkar, Dhiman and First Letter Of Title is N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N
T. R. Valkute, Arkile, M. A., Sarkar, D., and Bhattacharya, A. K., “Naturally occurring anti-TB agents: isolation, chemical transformations and in vitro antitubercular activities of secondary metabolites of rhizomes of alpinia galanga”, Planta Medica International Open, vol. 3, no. 3, pp. e55-e59, 2016.
M. B. Bhalerao, Dhumal, S. T., Deshmukh, A. R., Nawale, L. U., Khedkar, V. M., Sarkar, D., and Mane, R. A., “New bithiazolyl hydrazones: novel synthesis, characterization and antitubercular evaluation”, Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 2, pp. 288–294, 2017.
M. S. Said, Chinchansure, A. A., Nawale, L., Durge, A., Wadhwani, A., Kulkarni, S. S., Sarkar, D., and Joshi, S. P., “New butenolide cinnamate and other biological active chemical constituents from Polygonum glabrum”, Natural Product Research, vol. 29, no. 22, pp. 2080-2086, 2015.
A. A. Chinchansure, Arkile, M. A., Shinde, D. R., Sarkar, D., and Joshi, S. P., “New dinor-cis-labdane diterpene and flavonoids with antimycobacterium activity from colebrookea oppositifolia”, Planta Medica Letters, vol. 3, no. 1, pp. e20-e24, 2016.
R. R. Kulkarni, Shurpali, K., Khedkar, V. M., Puranik, V. G., Sarkar, D., and Joshi, S. P., “New pimarane diterpenes and other antimycobacterial metabolites from anisochilus verticillatus”, Natural Product Research, vol. 30, no. 6, pp. 675-681, 2016.
A. Khan and Sarkar, D., “Nitrate reduction pathways in mycobacteria and their implications during latency”, Microbiology-SGM, vol. 158, pp. 301-307, 2012.
S. Akhtar, Khan, A., Sohaskey, C. D., Jagannath, C., and Sarkar, D., “Nitrite reductase NirBD is induced and plays an important role during in vitro dormancy of mycobacterium tuberculosis”, Journal of Bacteriology, vol. 195, no. 20, pp. 4592-4599, 2013.
T. S. Chitre, Patil, S. M., Sujalegaonkar, A. G., Asgaonkar, K. D., Khedkar, V. M., Garud, D. R., Jha, P. C., Gaikwad, S. Y., Kulkarni, S., Choudhari, A., and Sarkar, D., “Non nucleoside reverse transcriptase inhibitors, molecular docking studies and antitubercular activity of thiazolidin-4-one derivatives”, Current Computer-Aided Drug Design, vol. 15, no. 5, pp. 433-444, 2019.
M. H. Shaikh, Subhedar, D., Nawale, L., Sarkar, D., Khan, F. A. Kalam, Sangshetti, J., and Shingate, B. B., “Novel benzylidenehydrazide-1,2,3-triazole conjugates as antitubercular agents: synthesis and molecular docking”, Mini Reviews in Medicinal Chemistry, vol. 18, 2018.
S. Agrawal, Gample, S., Yeware, A., and Sarkar, D., “Novel gene similar to nitrite reductase (NO forming) plays potentially important role in the latency of tuberculosis”, Scientific Reports, vol. 11, no. 1, p. 19813, 2021.
A. Yeware and Sarkar, D., “Novel red fluorescence protein based microplate assay for drug screening against dormant mycobacterium tuberculosis by using paraffin”, Tuberculosis, vol. 110, pp. 15-19, 2018.
U. Singh, Akhtar, S., Mishra, A., and Sarkar, D., “Novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents”, Journal of Microbiological Methods, vol. 84, no. 2, pp. 202-207, 2011.
D. D. Subhedar, Shaikh, M. H., Nawale, L., Yeware, A., Sarkar, D., Khan, F. A. Kalam, Sangshetti, J. N., and Shingate, B. B., “Novel tetrazoloquinoline-rhodanine conjugates: highly efficient synthesis and biological evaluation”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 9, pp. 2278-2283, 2016.
D. D. Subhedar, Shaikh, M. H., Shingate, B. B., Nawale, L., Sarkar, D., and Khedkar, V. M., “Novel tetrazoloquinoline-thiazolidinone conjugates as possible antitubercular agents: synthesis and molecular docking”, Medchemcomm, vol. 7, no. 9, pp. 1832-1848, 2016.